Interpretation and quantification of immunostains

被引:179
作者
Seidal, T [1 ]
Balaton, AJ
Battifora, H
机构
[1] Cent Hosp Karlstad, Dept Pathol, S-65185 Karlstad, Sweden
[2] Ctr Pathol, Bievres, France
[3] Pacific Coast Reference Labs, Cypress, CA USA
关键词
immunohistochemistry; standardization; quantification;
D O I
10.1097/00000478-200109000-00013
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Despite the fact that immunohistochemistry is widely used in routine diagnostic work and is a very common part of scientific reports in pathology and cytology, its standardization still lags behind. Interpretation of immunostains should be based on microanatomic distribution of the staining, proportion of positively stained cells, staining intensity, if relevant, and cutoff levels. These parameters should be shown to be reasonably reproducible and should be clearly defined in publications. Uniformity in the setting of thresholds could probably benefit from interlaboratory control materials containing defined amounts of the target antigen. Reliable and precise quantitative immunohistochemistry requires the use of control materials containing defined amounts of the target antigen and processed alongside the specimen combined with automated computer-assisted microspectrophotometry. Application of these suggestions is hoped to improve standardization and to facilitate communication in the field of immunohistochemistry.
引用
收藏
页码:1204 / 1207
页数:4
相关论文
共 20 条
[1]  
Allred DC, 1998, MODERN PATHOL, V11, P155
[2]  
Battifora H, 1993, APPL IMMUNOHISTO M M, V1, P39
[3]  
BATTIFORA H, 1990, LAB INVEST, V62, P8
[4]  
Biesterfeld S, 1996, ANTICANCER RES, V16, P2497
[5]  
Chan J K, 1998, Adv Anat Pathol, V5, P314, DOI 10.1097/00125480-199809000-00003
[6]  
FIELD JK, 1992, ANTICANCER RES, V12, P613
[7]   IMMUNOREACTIVITY FOR BER-EP4 IN ADENOCARCINOMAS, ADENOMATOID TUMORS, AND MALIGNANT MESOTHELIOMAS [J].
GAFFEY, MJ ;
MILLS, SE ;
SWANSON, PE ;
ZARBO, RJ ;
SHAH, AR ;
WICK, MR .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (06) :593-599
[8]   THE C-ERB B-2 PROTOONCOGENE IN HUMAN PANCREATIC-CANCER [J].
HALL, PA ;
HUGHES, CM ;
STADDON, SL ;
RICHMAN, PI ;
GULLICK, WJ ;
LEMOINE, NR .
JOURNAL OF PATHOLOGY, 1990, 161 (03) :195-200
[9]   IMMUNOCYTOCHEMISTRY TODAY - PROBLEMS AND PRACTICE [J].
HEYDERMAN, E ;
WARREN, PJ ;
HAINES, AMR .
HISTOPATHOLOGY, 1989, 15 (06) :653-658
[10]   BER-EP4 - NEW MONOCLONAL-ANTIBODY WHICH DISTINGUISHES EPITHELIA FROM MESOTHELIA [J].
LATZA, U ;
NIEDOBITEK, G ;
SCHWARTING, R ;
NEKARDA, H ;
STEIN, H .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (03) :213-219